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Abstract
Campylobacter jejuni along with C. coli are major cause of human gastroenteritis worldwide.
So far, the human immune response against Campylobacter is not entirely clear. We hypoth-
esize that it is coordinated by an interaction between pro-inflammatory and regulatory cyto-
kines which is influenced by bacterial and host-individual differences. Accordingly, we used
peripheral blood mononuclear cells (PBMC) from healthy donors to study the primary sys-
temic immune response to C. jejuni and C. coli. PBMC were stimulated by different strains of
C. jejuni and C. coli for three time points (5, 10, 24 hours). The production of the pro-inflam-
matory (IL-6, IL-8, IFN-γ) and the regulatory (IL-10) cytokines were measured by ELISA. All
strains induced higher levels of IL-8 and IL-6 than IFN-γ and IL-10. In contrast to IL-8 and IL-
6, IL-10 showed a steeper increase over time. While IFN-γ did not show any further increase
between 10 and 24 hours. Interestingly, there was a significant correlation between IL-8 and
IL-10 which peaked at 24 hours. Despite the variability of the used bacterial strains, their
effect on cytokine production was less pronounced than the inter-person differences. The
strongest significant effect of the strain was on the level of IL-10. IL-10 and IL-6 were signifi-
cantly influenced by strain-person interaction. In conclusion, the systemic immune response
to C. coli and C. jejuni is characterized by an early pro-inflammatory reaction with later initia-
tion of regulatory immune response which is influenced mainly by the host, explaining the
individual variations in disease severity. Additional work is needed to determine the cellular
sources of the produced cytokines as well as the campylobacter molecules that might con-
tribute to this stimulation.
Introduction
Campylobacteriosis is the most common foodborne zoonosis in Europe with chicken consti-
tuting the main reservoir [1]. Most outbreaks in humans are related to chicken food or water-
borne sources [2]. Humans can get infected with multiple Campylobacter species, while the
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most pathogenic are C. jejuni and C. coli causing gastroenteritis [3]. However, the illness is
generally mild, some individuals develop severe post infectious sequelae such as irritable bowel
syndrome, reactive arthritis and Guillain-Barre´ syndrome [4].
The properties of the infecting strain and the host immune status are thought to be involved
in the disease development [2]. Epidemiological studies showed differences in susceptibility of
individuals to Campylobacter. Some patient groups are more susceptible like very young chil-
dren, elderly people or those who suffer from defects in humoral or cell mediated immunity
[5]. Such patients experience severe fatal clinical symptoms and are more likely to develop
chronic carrier status and recurrent infection [6].
Despite the high prevalence of campylobacteriosis, it is still unclear how exactly the organism
causes disease in humans. Several studies have shown that Campylobacter is able to induce acute
inflammatory enteritis [7–9], pointing to a possible role of polymorphonuclear leucocytes [6].
In vitro experiments on a range of human-derived cell lines [8, 10, 11] have shown that C. jejuni
induce IL-8 which have also been reported in stools of patients with campylobacteriosis [12].
IL-8 is one of the earliest pro-inflammatory cytokines that are induced by enteric bacteria [13].
Moreover, secretion of IL-6 following stimulation by C. jejuni [8, 9, 14] and C. coli was also
reported [15]. Beside its inflammatory action, IL-6 plays a critical role in governing the transi-
tion from innate to acquired immunity [13]. An in vitro model of C. jejuni infection using
healthy human gut explant showed marked induction of IFN-γ with a modest increase of IL-22
and IL-17A levels [16]. IFN-γ was also shown to be associated with protection from campylo-
bacteriosis [4]. Furthermore, C. jejuni was shown to induce the production of various pro-
inflammatory cytokines as well as the regulatory cytokine IL-10 by dendritic cells [9].
Our hypothesis was that the immune response against Campylobacter is determined by a
balance between pro-inflammatory and regulatory cytokines which is influenced by bacterial
strains as well as the host immune system. Disturbance in this balance might drive the host
immune response from mild to severe disease.
So far, most of the studies that examined the human immune response to Campylobacter
used either cell line models [8, 10, 17] or human gut epithelial cells [10, 18]. The drawback of
using cell lines is that it does not always reflect the natural reaction [11, 19]. Using primary tis-
sue explant represents the gold standard, however, it raises ethical questions. In contrast,
peripheral blood mononuclear cells (PBMC) can easily be obtained and have been used as a
model to determine the cytokine response induced by enteric bacteria [20]. C. jejuni was
shown to invade the colonic mucosa [16, 19, 21], suggesting an interaction with immune cells
in intestinal mucosal compartments. Although PBMC cannot fully represent the immune cells
in the intestinal mucosa, they share phenotypical similarities like the pattern recognition
receptors on lymphocytes and macrophages [13] which could constitute a link between both
populations. Moreover, C. jejuni was shown to persist within peripheral blood monocytes for
up to 7 days [22]. Therefore, examination of the immune-stimulatory effect of C. jejuni and C.
coli on PBMC can provide important indications of the mucosal immune response to these
bacteria. Accordingly, the present study aimed to compare the production of pro-inflamma-
tory (IL-8, IL-6 and IFN-γ) and regulatory (IL-10) cytokines by human PBMC following in
vitro stimulation with various strains of C. jejuni and C. coli and examine whether there are
inter-strain or inter-person differences in the immune response against Campylobacter.
Materials and methods
Study group
Blood samples from ten clinically healthy human volunteers were obtained by venepuncture
and collected into sterile sodium heparin containing vacuette tubes (Greiner Bio-One vacuette
PBMC stimulation by C. jejuni and C. coli
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GmbH). The group included five men and five women with a mean age of 43, range (24–64
years). Ethical clearance to use human subjects was obtained from the designated health facility.
Written consent was obtained from each person upon information of the use of blood samples.
The biological material was used anonymized. The study was approved by the institutional eth-
ics committee at the Department of Pathobiology and Infectious Disease, University of Bern,
and complied with the Declaration of Helsinki.
Bacterial strains
Six genotypically characterized campylobacter strains were used. Two were C. coli of the same
genotype, one chicken (Mon2065: ST-2142, fla66) and one human clinical isolate (N08-1636:
ST-2142, fla66). Four strains were C. jejuni, three chicken isolates (Mon1296: ST-45, fla307;
Mon1354: ST-45, fla307 and Mon227: ST-45, fla66) and one human isolate from a sepsis case
(BK: ST-572, fla96). The bacteria were grown on tryptone soya agar plates with sheep blood
(Oxoid) at 42˚C under microaerophilic conditions for 24h, then harvested by washing with
sterile phosphate buffered saline (PBS, GIBCO1) and centrifugation at 10˚C for 10min at
4000g. This was followed by washing and subsequent re-suspension in PBS to an optical den-
sity of 1.0 McFarland. The bacteria were then diluted 1:200 in cell culture medium and subse-
quently used in the stimulation experiments.
Isolation and stimulation of human PBMC
PBMC were isolated from whole blood using Ficoll (1077, GE Healthcare) gradient centrifuga-
tion. Equal volumes of blood and PBS-0.3mM EDTA were mixed and layered over Ficoll solution.
After centrifugation (1260 g, 30 min), PBMC were collected from the interface, washed twice with
PBS and re-suspended in cell culture medium to a final concentration of 1x106 cells / ml. PBMC
were seeded in duplicates into 24 well tissue culture plates and incubated with the same volume of
each of the six bacterial suspensions with multiplicity of infection (MOI) 1.5 or lipopolysaccharide
as a positive control (LPS, E. coli serotype O55-B5, 1μg/ml, Sigma-Aldrich, Buchs, Switzerland) or
culture medium alone (mock) for 5, 10 and 24 hours at 37˚C. Cell culture supernatants were col-
lected, filtered through 0.2 μm syringe filters (Acrodisc1, Pall Corporation) and kept at -80˚C
until cytokine analysis using enzyme-linked immunosorbent assay (ELISA).
All cell cultures were performed in RPMI 1640 containing 10% native autologous human
serum, nonessential amino acids (1%), MEM vitamins (100μM), sodium pyruvate (1mM) and
gentamicin (25 μg/ml) to prevent bacterial overgrowth.
ELISA
IL-6, IL-8, IL-10 and IFN-γ in cell culture supernatants were determined using sandwich
ELISA kits (PeliKine compactTM, Sanquin) according to the manufacturer’s instructions. The
samples were measured in triplicates, a standard curve of the relevant recombinant protein
was included to calculate cytokine concentrations in the cell culture supernatant using SOFT-
max program (SOFTmax1 PRO, version 3.1.2, Molecular Devices).
Statistical analysis
The NCSS 9 software program was used for statistical analyses. Descriptive statistics were run
on the data and Kolmogrov–Smirnov test showed that the data were not normally distributed.
Therefore, the data were transformed using natural logarithm.
Balanced design analysis of variance MANOVA was used to examine the influence as well as
the interaction of the factors “Person” [10 persons], “Campylobacter strain” [C. coli (Mon2065
PBMC stimulation by C. jejuni and C. coli
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and N08-1636); C. jejuni (Mon1296, Mon1354, Mon227 and BK)] and “Time point of incuba-
tion” [5, 10 and 24 hours] on the production of cytokines (Table 1). Table 1 Factors influencing
the production of pro-inflammatory as well as regulatory cytokines by PBMC stimulated with
different strains of Campylobacter jejuni and C. coli. Two statistical models (a, b) were used to
examine the effect of person (Person), Campylobacter strains (Strains) and time of incubation
(Time point) of the strains with PBMC on the cytokine production (Parameters). Two MAN-
OVA models were run with the levels of cytokines as outcome variables and “Strains” as fixed
factor (Table 1). “Time point” was then set in one model (Table 1A) as the random factor with
“Person” as fixed factor. While, in the other model (Table 1B), “Time point” was the fixed factor
and “Person” was the random factor. This was done to allow the analysis of the effect of all three
parameters and also test for interactions. For significant factors in MANOVA, a pairwise multi-
ple comparison with a Bonferroni correction of the significant level was used to determine sig-
nificant differences in the level of cytokines between the different time points as well as bacterial
strains and controls (mock, LPS) (Fig 1). For comparison between time points within stimuli
the Bonferroni multiple comparison test for two factor interaction was applied. Correlation
between levels of cytokines for each time point was determined using Pearson correlation coef-
ficient (Fig 2).
On each occasion, p values 0.05 were regarded as significant.
Results
Cytokines induction show significant inter-person variations and is
influenced by person-Campylobacter strain interaction
PBMC from ten healthy donors were stimulated in vitro with six different Campylobacter
strains of chicken and human sources, LPS as a positive control or left without stimulation
(mock). The levels of pro-inflammatory (IL-8, IL-6, IFN-γ) and regulatory (IL-10) cytokines
Table 1. Factors influencing the production of pro-inflammatory as well as regulatory cytokines by
PBMC stimulated with different strains of Campylobacter jejuni and C. coli*.
a) Person and Strains were set as fixed variables, while Time point was set as random variable.
Cytokine Factors
Person Strains Interaction
Person / Strains
IL-8 Sig (0.000) n.sig n.sig
IL-6 Sig (0.000) n.sig n.sig
IL-10 Sig (0.000) Sig (0.008) Sig (0.001)
IFN-γ Sig (0.000) n.sig Sig (0.000)
b) Time point and Strains were set as fixed variables, while person was the random variable.
Cytokine Factors
Time point Strains Interaction
Time point / Strains
IL-8 Sig (0.000) Sig.(0.013) n.sig
IL-6 Sig (0.000) Sig.(0.001) Sig (0.005)
IL-10 Sig (0.000) Sig. (0.005) n.sig
IFN-γ Sig (0.000) n.sig Sig (0.000)
* Two statistical models (a, b) were used to examine the effect of person (Person), Campylobacter strains
(Strains) and time of incubation (Time point) of the strains with PBMC on the cytokine production
(Parameters). Significant p-values are indicated in brackets.
Sig. means statistical significance of p 0.05. n.sig means not significant.
doi:10.1371/journal.pone.0171350.t001
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were measured in PBMC culture supernatants using ELISA. MANOVA was used to determine
whether the cytokine production is influenced by the individual person, Campylobacter strains
or post-stimulation time point (Table 1).
There were no marked differences in the cytokine production between C. jeuni and C. coli,
human and chicken isolates, or the genotypes of the strains. In contrast, the variables “Person”
(Table 1A) as well as “Time point” (Table 1B) had a significant effect on the production of IL-8,
IL-6, IFN-γ as well as IL-10. The variable “Strains" had a significant influence on IL-10 regardless
of the model used (Table 1A and 1B), while, IL-8 and IL-6 were significantly influenced by the
“Strains” only when “Person” was set as a random variable (Table 1B). Conversely, there was no
significant influence of the “Strains” on the production of IFN-γ (Table 1A and 1B). Interest-
ingly, the interaction between strains and person “Person/Strains” (Table 1A) had a significant
effect on IL-10 and IFN-γ, while the interaction between strains and time point “Time point/
Strains” had a significant effect on IL-6 and IFN-γ (Table 1B).
All Campylobacter strains induce an early pro-inflammatory response
followed by IL-10 in human PBMC
Comparing the production of cytokines between mock and Campylobacter stimulated PBMC
showed a significant elevation of IL-8, IL-6, IFN-γ and IL-10 as compared to mock (Fig 1).
Fig 1. Induction of pro-inflammatory and regulatory cytokines by human PBMC following stimulation. Freshly isolated peripheral blood
mononuclear cells (PBMC) from ten donors were left unstimulated (mock), stimulated with LPS, four C. jejuni strains [human (BK) and chicken
(Mon1296, Mon1354 and Mon227) isolates] or two C. coli [human (N08-1636) and chicken (Mon2065) isolates] for three time points (5, 10 and
24 hours). The concentrations (pg/ml) of IL-8, IL-6, IFN-γ and IL-10 were measured in cell culture supernatants using ELISA. Each data point
represents mean values for each type of stimulation. Comparisons between the different stimuli as well as between the three time points were
performed using Bonferroni pairwise multiple comparison. The sign *mock indicates significant differences between mock and all other stimuli.
The signs *5h and *10h indicate a significant differences to the time point 5 hours and 10 hours, respectively. The asterisks indicate statistical
significant differences of p 0.05.
doi:10.1371/journal.pone.0171350.g001
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Freshly isolated peripheral blood mononuclear cells (PBMC) from ten donors were left un-
stimulated (mock), stimulated with LPS, four C. jejuni strains [human (BK) and chicken
(Mon1296, Mon1354 and Mon227) isolates] or two C. coli [human (N08-1636) and chicken
(Mon2065) isolates] for three time points (5, 10 and 24 hours). The concentrations (pg/ml) of
IL-8, IL-6, IFN-γ and IL-10 were measured in cell culture supernatants using ELISA. Each data
point represents mean values for each type of stimulation. Comparisons between the different
stimuli as well as between the three time points were performed using Bonferroni pairwise
multiple comparison. The sign mock indicates significant differences between mock and all
other stimuli. The signs 5h and 10h indicate a significant differences to the time point 5
hours and 10 hours, respectively. The asterisks indicate statistical significant differences of
p 0.05.
This was the case for all strains and the three time points (5, 10, 24 hours), except for the
level of IFN-γ following 5 hours stimulation which was not significantly different from mock.
The secretion of IL-8 was the highest over the three examined time periods, followed by IL-6
then IL-10, while IFN-γ was induced at a very low level.
Moreover, the levels of IL-8 and IL-6 showed a significant steady increase over time. Con-
versely, the level of IFN-γ showed only a significant increase between 5 and 10 hours stimula-
tion, but no additional significant enhancement was observed between 10 and 24 hours.
Strikingly, the increase in IL-10 over time was steeper than the pro-inflammatory cytokines.
Moreover, there were no significant differences in the levels of the inflammatory cytokines
between stimulation with LPS and any of the Campylobacter strains. Conversely, IL-10 induc-
tion by LPS was significantly higher compared to the six Campylobacter strains.
Fig 2. Correlation between the levels of IL-8, IL-6 and IL-10 following stimulation with the six strains of
Campylobacter. Pearson Correlation coefficient was used to examine the correlation between the levels of IL-8 and IL-6
(A), IL-8 and IL-10 (B) and IL-6 and IL-10 (C). Each data point represents stimulation with one strain of Campylobacter. P
values 0.05 were considered significant.
doi:10.1371/journal.pone.0171350.g002
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Association between the pro-inflammatory and regulatory cytokines in
Campylobacter- stimulated PBMC
A significant correlation was found between IL-6 and IL-8 production at all time-points (Fig
2A). Pearson Correlation coefficient was used to examine the correlation between the levels of
IL-8 and IL-6 (A), IL-8 and IL-10 (B) and IL-6 and IL-10 (C). Each data point represents stim-
ulation with one strain of Campylobacter. P values 0.05 were considered significant. This
was stronger after 5 hours (0.89) stimulation compared to 10 (0.80) and 24 (0.73) hours. Inter-
estingly, the correlation between IL-8 and IL-10 was significant with marked increase over
time (0.74, 0.78, and 0.85) (Fig 2B). The correlation between IL-6 and IL-10 was lower than
that between IL-8 and IL-10 (Fig 2C). There was no correlation between IFN-γ and any of the
other cytokines (data not shown).
Discussion
The human immune system consists of a network of multiple immune-regulatory control ele-
ments that coordinate the immune response elicited by infectious microbes [13]. So far, no
studies have been undertaken to analyse whether the immune response against Campylobacter
in humans is controlled by a balance between pro-inflammatory and regulatory cytokines.
Therefore, the aim of the present study was to examine the primary systemic immune response
of the two medically important Campylobacter species C. jeuni and C. coli on PBMC from
healthy individuals. Our results show significant effect of persons on both pro-inflammatory
(IL-8, IL-6, IFN-γ) and regulatory (IL-10) cytokines in response to stimulation with Campylo-
bacter. This might be linked to individual variations in the constitutive expression levels
of toll-like receptors (TLR) [23] which recognize pathogen associated molecular patterns
(PAMPs) and generate signals that promote an immune response [13]. Consistent with this
explanation, we found that the production of pro-inflammatory (IL-8, IL-6, IFN-γ) cytokines
by LPS is significantly influenced by persons (S1 Table).
An inter-strain difference in the cytokine production was also observed but less pro-
nounced than the inter-person difference even though the strains used in this study were of
different species, different genotypes and either human or chicken isolates. A stronger effect
of the strains was observed mainly in IL-10 production, which might be due to variations
between the Campylobacter strains in the O-linked glycosylation structure of flagella that
engage siglec-10 receptors leading to positive regulation of IL-10 [24]. Siglec-10 was found to
be expressed on monocytes, minor population of natural killer cells [25] as well as macro-
phages and monocyte derived dendritic cells [24].
It has been reported previously that the interaction of Campylobacter with human intestinal
epithelial cells increases IL-8 [10–12] and IL-6 secretion [14]. Here, we found that the secretion
of IL-8 was the highest over the three time periods (5, 10 and 24 hours), followed by IL-6 then
IL-10, while IFN-γ was induced at a very low level. The peak levels of IL-8 and IL-6 are consis-
tent with studies on clinical human cases of campylobacteriosis [7, 12]. This points to the
importance of these two cytokines in the defence against infection with Campylobacter. IL-8
can be produced by any cells with TLRs that are involved in the innate immune response.
Among them, macrophages are the first cells to release IL-8 in order to recruit other cells.
While neutrophils are the primary target cells of IL-8, there is a relatively wide range of cells
like endothelial cells, macrophages and others that respond to this cytokine [13]. Moreover,
IL-6 is secreted by macrophages, T cells and endothelial cells to stimulate immune response
during infection leading to synthesis of a variety of inflammatory mediators including neutro-
phils [13]. The involvement of neutrophils in host defence against C. jejuni and C. coli has
been shown [26].
PBMC stimulation by C. jejuni and C. coli
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Interestingly, a significant steady increase over time was observed for IL-8 and IL-6, while,
the increase in IFN-γ did not show a significant enhancement between 10 and 24 hours. This
finding together with the lower production of IFN-γ by PBMC from all donors compared to
IL-8 and IL-6 might be attributed to using different campylobacter strains than in other studies
which showed a critical role of IFN-γ in immune response to campylobacter infection [16, 27].
Another explanation could be that the donors have been previously experienced Campylo-
bacter infection. This is consistent with the findings that IFN-γ production is more robust after
the first exposure to campylobacter than subsequent exposures [28]. The low level of IFN-γ
coincide with an increase in IL-10. While, the levels of IFN-γ and IL-10 were similar at 5
hours, IL-10 showed a significant up-regulation at 10 and 24 hours post stimulation and hence
exceeding the level of IFN-γ. This might explain the low level of IFN-γ as IL-10 is known to
downregulate the production of IFN-γ [29].
The increase in IL-10 over time was steeper than the pro-inflammatory cytokines, suggest-
ing that the increase in IL-8 and IL-6 observed up to 10 hours post-exposure results in an ele-
vation of IL-10. A strong correlation was found between IL-8 and IL-6 at all time-points, but it
shows a decrease over time. Conversely, the correlation between IL-8 and IL-10 increased over
time. The correlation between IL-6 and IL-10 was significant but lower than that between IL-8
and IL-10 and shows a decrease over time. This indicates that Campylobacter is capable of
inducing an early strong pro-inflammatory response in human immune cells which is then
shifted gradually towards a regulatory immune response, most probably to control the damag-
ing inflammation. This is in accordance with Klancnik et al. [15] who found beside the high
level of anti-inflammatory cytokines, a pronounced increase in IL-10 in the plasma between
day 1 and 8 post infection in mice infected with C. coli. Moreover, Campylobacter may benefit
from IL-10 production as this might allow the bacteria to persist longer. In chickens, breeds
that produce higher levels of IL-10 following Campylobacter colonization act as asymptomatic
carrier compared to breeds with low IL-10 production [30]. Consistent with other studies [8,
9, 16], levels of cytokines produced by the examined campylobacter strains were similar to that
occurred in response to stimulation by LPS (S1 Fig). This suggests a role of lipooligosacchar-
ides in initiating an immune response upon infection with campylobacter species.
In summary, we found that C. jejuni and C. coli elicit an early strong pro-inflammatory re-
sponse mediated by IL-6 and IL-8. This was associated with a late anti-inflammatory response
represented by IL-10 production. The production of inflammatory cytokines was significantly
influenced by individual variations rather than by the Campylobacter strains. Strikingly, the IL-
10 induction was influenced by both the bacterial strain and a person-strain interaction, which
might play an important role in reducing the severity of symptoms after infection and the time
of shedding after resolution of symptoms. This corroborates our hypothesis that campylobacter-
iosis is not only driven by bacterial virulence, but rather by the interaction between strain and
host immune system, suggesting that the individual differences in the immune reaction might
influence the severity of the disease. However, the small number of human subjects involved
might not be able to fully reveal the variability of individual responses. A limitation of the pres-
ent study is the lack of data on the mechanism used by campylobacter to induce stimulation of
cytokines as well as the type of immune cells that produce these cytokines. Therefore, further
study is required to determine the campylobacter molecules contribute to immune stimulation
as well as the overall spectrum of cytokines induced and their cellular sources.
Supporting information
S1 Fig. Correlation between the levels of IL-8, IL-6 and IL-10 following stimulation with
the six strains of Campylobacter and LPS using Pearson Correlation coefficient. Each data
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point represents mean value stimulation of one person with the six strains of Campylobacter or
LPS. P values 0.05 were considered significant.
(TIF)
S1 Table. Effect of person on cytokine production by LPS using One Way ANOVA.
(DOCX)
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